Literature DB >> 17568023

Weighing the hazards of erythropoiesis stimulation in patients with cancer.

Fadlo R Khuri1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568023     DOI: 10.1056/NEJMp078101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

Review 2.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

3.  Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.

Authors:  Mariana Chavez-MacGregor; Hui Zhao; Shenying Fang; Tomasz P Srokowski; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  Cancer       Date:  2011-02-24       Impact factor: 6.860

4.  Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.

Authors:  Dawn L Hershman; Donna L Buono; Jennifer Malin; Russell McBride; Wei Yann Tsai; Alfred I Neugut
Journal:  J Natl Cancer Inst       Date:  2009-11-10       Impact factor: 13.506

5.  Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancer.

Authors:  Joanna Van Erps; Matti Aapro; Karen MacDonald; Pierre Soubeyran; Matthew Turner; Hans Warrinnier; Tara Albrecht; Ivo Abraham
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

Review 6.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

7.  Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.

Authors:  Alfonso Quintás-Cardama; Fabio Pires De Souza Santos; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Ahmed Awais; Gautam Borthakur; Jorge Cortes
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

8.  Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.

Authors:  Hassan N Ibrahim; Robert N Foley; Rui Zhang; David T Gilbertson; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

9.  Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahemd E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

Review 10.  Treatment strategies in elderly patients with multiple myeloma: current status.

Authors:  Hang Quach; H Miles Prince; Linda Mileshkin
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.